You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

Article metrics

Article menu
XML
Oncolytic and local immunotherapy
Original research
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: October 2020 to June 2025

AbstractFullPdf
Oct 2020424424168
Nov 2020303303112
Dec 202013513564
Jan 202114714794
Feb 202115615682
Mar 202113413462
Apr 2021909035
May 202111411465
Jun 202111411447
Jul 202111111143
Aug 2021898949
Sep 2021939357
Oct 202110210257
Nov 2021999758
Dec 2021828226
Jan 2022899129
Feb 2022404323
Mar 2022899534
Apr 2022879230
May 202214114763
Jun 202211713770
Jul 202211411665
Aug 202213013284
Sep 202214114786
Oct 202211411781
Nov 202217617654
Dec 202211912041
Jan 202312312368
Feb 202317217352
Mar 202312612771
Apr 2023959641
May 2023818339
Jun 2023586031
Jul 202311912044
Aug 202311511441
Sep 2023575826
Oct 2023505021
Nov 2023555521
Dec 2023494918
Jan 2024464720
Feb 2024444421
Mar 2024525254
Apr 2024505140
May 2024474724
Jun 2024717424
Jul 2024636536
Aug 2024454520
Sep 2024555535
Oct 2024727257
Nov 2024838451
Dec 2024858559
Jan 202511111267
Feb 202510910937
Mar 2025535325
Apr 202511011068
May 2025717154
Jun 2025646437
Total588159522881